CHRONIC KIDNEY DISEASE MANAGEMENT IN PRIMARY CARE HANDBOOK REFRESHED FOR HCPs
Breonny Robson, GM Clinical and Research
Kidney Health Australia
Dr Chris Bollen GP, Oakden Medical Centre &
PEAK Committee Member, Kidney Health Australia
Professor Shilpa Jesudason, Nephrologist
Professor of Medicine, University of Adelaide,
Director of Dialysis, Royal Adelaide Hospital &
PEAK Committee Member, Kidney Health Australia
Chris Picton MP, Minister for Health and Wellbeing
Government of South Australia
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.
The number of Australians treated for kidney failure has doubled in the last two decades, causing widespread treatment shortages, increasing costs, and plunging thousands of Australians into highly invasive and life-altering dialysis. With 1.8 million people currently unaware they have kidney disease, this number will only continue to grow.
Breonny Robson, General Manager, Clinical and Research at Kidney Health Australia, said: “The new edition of the GP handbook helps health professionals working in primary care to identify people at risk of CKD in their practice and proactively diagnose CKD. It outlines key strategies to slow the progression of CKD and reduce cardiovascular risk, including simple colour-coded action plans for different stages of the disease.”
Ms Robson added, “It’s an exciting time in CKD care, with new treatments now available that have been shown to slow the progression of CKD to kidney failure by 15 years or more. The handbook contains significant new information on using these medications in people with CKD so that their health outcomes and quality of life can be extended for many years to come.”
The handbook is endorsed by Australian and New Zealand Society of Nephrology (ANZSN), the Renal Society of Australasia (RSA) and the Australian Primary Healthcare Nurses Association (APNA) and Australian College of Rural and Remote Medicine (ACRRM). It has been approved as an Acceptable Clinical Resource by the Royal Australian College of General Practitioners (RACGP).
South Australian Minister of Health and Wellbeing Chris Picton launched the handbook at an event on World Kidney Day, 14th March, at Royal Adelaide Hospital.
The handbook is available from Kidney Health Australia in hardcopy or free download here https://kidney.org.au/health-professionals/ckd-management-handbook
You Might also like
-
Health Minister’s Awards for Nursing Trailblazers
An ACT nurse dedicated to giving people more dignity and choice in their final days was earlier this week night named the inaugural Health Minister’s Nursing Trailblazer at an awards ceremony in Sydney.
Lord Nigel Crisp, Co-Chair Nursing Now and Australian College of Nursing President, Professor Christine Duffield FACN presented the inaugural Health Minister’s Nursing Trailblazer Award to Nikki Johnston MACN, a Palliative Care Nurse Practitioner based in Canberra at Calvary Health Care’s Clare Holland House.
-
Improved treatment in advanced-stage Hodgkin lymphoma
A global clinical trial successfully reduced toxicity and side effects in advanced stage Hodgkin lymphoma patients by using a modified treatment regimen.
Australian Health Journal spoke with Professor Mark Hertzberg in his role in the ALLG HD10 Clinical Trial and as a former Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group (ALLG), an organisation involved in improving the treatments and lives of blood cancer patients.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.